Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 46,700
- Avg volume
- 32,134
- Day's range
- $0.07 – $0.10
- Shares out
- —
- Stochastic %K
- 39%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Pharmala Biotech Holdings Inc., a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredients under the LaNeo brand. The company is headquartered in Vancouver, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Website
- https://pharmala.ca
- Address
- 1055 West Georgia Street, P.O. Box 11117, Vancouver, Canada
Latest news
No headlines yet.
